logo

Krystal Biotech, Inc. (KRYS)



Trade KRYS now with
  Date
  Headline
5/18/2020 11:04:01 PM Krystal Biotech Prices Underwritten Public Offering Of 2.28 Mln Shares At $55.00/shr
10/10/2019 8:04:24 AM Krystal Biotech Receives Positive EMA Opinion On Orphan Designation For KB105
9/27/2019 8:07:28 AM Krystal Biotech Announces Grant Of New Patent For KB103
8/5/2019 8:08:18 AM Krystal Biotech Q2 Net Loss $5.3 Mln Or $0.37/Shr Vs Loss $2.3 Mln Or $0.22/Shr Last Year
6/24/2019 8:12:58 AM Krystal Biotech Announces Positive Results From Phase 2 Clinical Trial Of KB103
11/5/2018 8:10:41 AM Krystal Biotech Q3 Net Loss Narrows To $2.8 Mln From $5.3 Mln Last Year
10/17/2018 4:02:32 PM Krystal Biotech Begins Public Offering Of $60.0 Mln Of Common Stock
10/15/2018 7:47:27 AM Krystal Announces Positive Interim Results From Placebo-Controlled Phase 1/2 Clinical Trial Of KB103
8/23/2018 8:08:22 AM Krystal Biotechs’ KB105 Gets Rare Pediatric Disease Designation From The FDA To Treat Patients With TGM-1-deficient ARCI